{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T19:32:36Z","timestamp":1757705556788,"version":"3.37.3"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Chinese Cardiovascular Association-Access found","award":["2017-CCA-AF-002"],"award-info":[{"award-number":["2017-CCA-AF-002"]}]},{"name":"Chinese Cardiovascular Association-V.G found","award":["2017-CCA-VG-003"],"award-info":[{"award-number":["2017-CCA-VG-003"]}]},{"name":"Municipal Science and Technology Commission of Beijing","award":["Z161100000116073"],"award-info":[{"award-number":["Z161100000116073"]}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"crossref","award":["2017YFC0908800"],"award-info":[{"award-number":["2017YFC0908800"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009601","name":"Beijing Municipal Administration of Hospitals Ascent Plan","doi-asserted-by":"crossref","award":["DFL20150601"],"award-info":[{"award-number":["DFL20150601"]}],"id":[{"id":"10.13039\/501100009601","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Beijing Municipal Health Commission \u201cProject of Science and Technology Innovation Center\u201d","award":["(PXM2019_026272_000006)( PXM2019_026272_000005)"],"award-info":[{"award-number":["(PXM2019_026272_000006)( PXM2019_026272_000005)"]}]},{"name":"Beijing Municipal Administration of Hospitals Mission plan","award":["(SML20180601)"],"award-info":[{"award-number":["(SML20180601)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12944-019-1074-8","type":"journal-article","created":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T13:02:22Z","timestamp":1559394142000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Comparison of long-term outcomes of young patients after a coronary event associated with familial hypercholesterolemia"],"prefix":"10.1186","volume":"18","author":[{"given":"Xu","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaojun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ran","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziwei","family":"Xi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gexuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhui","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenggang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingwei","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinguo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujie","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luya","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,1]]},"reference":[{"issue":"3","key":"1074_CR1","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ijcard.2013.11.025","volume":"171","author":"GF Watts","year":"2014","unstructured":"Watts GF, Gidding S, Wierzbicki AS, Toth PP, Alonso R, Brown WV, Bruckert E, Defesche J, Lin KK, Livingston M, Mata P, Parhofer KG, Raal FJ, Santos RD, Sijbrands EJ, Simpson WG, Sullivan DR, Susekov AV, Tomlinson B, Wiegman A, Yamashita S, Kastelein JJ. Integrated guidance on the care of familial hypercholesterolaemia from the international FH Foundation. Int J Cardiol. 2014;171(3):309\u201325. \n                    24418289\n                    \n                  .","journal-title":"Int J Cardiol"},{"issue":"45","key":"1074_CR2","doi-asserted-by":"publisher","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","volume":"34","author":"B. G. Nordestgaard","year":"2013","unstructured":"Nordestgaard BG,Chapman MJ, Humphries SE, Ginsberg HN, Masana L, Descamps OS, Wiklund O, Hegele RA, Raal FJ, Defesche JC, Wiegman A, Santos RD, Watts GF, Parhofer KG, Hovingh GK, Kovanen PT, Boileau C, Averna M, Bor\u00e9n J, Bruckert E, Catapano AL, Kuivenhoven JA, Pajukanta P, Ray K, Stalenhoef AF, Stroes E, Taskinen MR, Tybj\u00e6rg-Hansen A; European Atherosclerosis Society Consensus Panel. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European atherosclerosis society. Eur Heart J 2013, 34: 3478-3490a. [PMID: 23956253].","journal-title":"European Heart Journal"},{"issue":"5","key":"1074_CR3","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/aje\/kwh236","volume":"160","author":"M. A. Austin","year":"2004","unstructured":"Austin MA, Hutter CM, Zimmern RL, Humphries SE. Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review. Am J Epidemiol 2004, 160(5): 407\u2013420. [PMID: 15321837].","journal-title":"American Journal of Epidemiology"},{"key":"1074_CR4","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.ijcard.2014.04.165","volume":"174","author":"Z Shi","year":"2014","unstructured":"Shi Z, Yuan B, Zhao D, Taylor AW, Lin J, Watts GF. Familial hypercholesterolemia in China: prevalence and evidence of underdetection and undertreatment in a community population. Int J Cardiol. 2014;174:834\u20136. \n                    24801084\n                    \n                  .","journal-title":"Int J Cardiol"},{"issue":"1","key":"1074_CR5","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0021-9150(98)00200-7","volume":"142","author":"ScientificSteeringCommitteeonbehalfoftheSimonBroomeRegister Group","year":"1999","unstructured":"ScientificSteeringCommitteeonbehalfoftheSimonBroomeRegister Group. Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Atherosclerosis. 1999;142(1):105\u201312. \n                    9920511\n                    \n                  .","journal-title":"Atherosclerosis."},{"issue":"36","key":"1074_CR6","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1093\/eurheartj\/ehv289","volume":"36","author":"D Nanchen","year":"2015","unstructured":"Nanchen D, Gencer B, Auer R, R\u00e4ber L, Stefanini GG, Klingenberg R, Schmied CM, Cornuz J, Muller O, Vogt P, J\u00fcni P, Matter CM, Windecker S, L\u00fcscher TF, Mach F, Rodondi N. Prevalence and management of familial hypercholesterolaemia in patients with acute coronary syndromes. Eur Heart J. 2015;36(36):2438\u201345. \n                    26142466\n                    \n                  .","journal-title":"Eur Heart J"},{"key":"1074_CR7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ahj.2016.08.001","volume":"181","author":"SA Rerup","year":"2016","unstructured":"Rerup SA, Bang LE, Mogensen UM, Engstr\u00f8m T, J\u00f8rgensen E, Pedersen F, Torp-Pedersen C, Gislason G, James S, Hagstr\u00f6m E, K\u00f8ber L, Fosb\u00f8l EL. The prevalence and prognostic importance of possible familial hypercholesterolemia in patients with myocardial infarction. Am Heart J. 2016;181:35\u201342. \n                    27823691\n                    \n                  .","journal-title":"Am Heart J"},{"issue":"1","key":"1074_CR8","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.atherosclerosis.2015.04.809","volume":"241","author":"G De Backer","year":"2015","unstructured":"De Backer G, Besseling J, Chapman J, Hovingh GK, Kastelein JJ, Kotseva K, Ray K, Reiner \u017d, Wood D, De Bacquer D, EUROASPIRE Investigators. Prevalence and management of familial hypercholesterolaemia in coronary patients: an analysis of EUROASPIRE IV, a study of the European Society of Cardiology. Atherosclerosis. 2015;241(1):169\u201375. \n                    25997074\n                    \n                  .","journal-title":"Atherosclerosis"},{"key":"1074_CR9","unstructured":"European Association for Cardiovascular Prevention & Rehabilitation, Reiner Z, Catapano AL, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman MJ, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Filardi PP, Riccardi G, Storey RF, Wood D. ESC\/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J. 2011, 32(14): 1769\u20131818. [PMID: 21712404]."},{"issue":"1","key":"1074_CR10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.atherosclerosis.2003.11.010","volume":"173","author":"Fernando Civeira","year":"2004","unstructured":"Civeira F. International panel on Management of Familial Hypercholesterolemia. Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia. Atherosclerosis. 2004, 173 (1): 55\u201368. [PMID: 15177124].","journal-title":"Atherosclerosis"},{"key":"1074_CR11","doi-asserted-by":"publisher","first-page":"3956","DOI":"10.1210\/jc.2012-1563","volume":"97","author":"M Benn","year":"2012","unstructured":"Benn M, Watts GF, Tybjaerg-Hansen A, Nordestgaard BG. Familial hypercholesterolemia in the Danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication. J Clin Endocrinol Metab. 2012;97:3956\u201364. \n                    22893714\n                    \n                  .","journal-title":"J Clin Endocrinol Metab"},{"key":"1074_CR12","unstructured":"Liu LS. Writing group of 2010 Chinese guidelines for the Management of Hypertension. 2010 Chinese guidelines for the management of hypertension. Zhonghua Xin Xue Guan Bing Za Zhi 2011, 39(7): 579\u2013615. [PMID: 22088239]."},{"key":"1074_CR13","doi-asserted-by":"crossref","unstructured":"American Diabetes Association. Introduction standards of medical care in diabetes-2018. Diabetes Care. 2018 Jan;41(Suppl 1):S13-S27. [PMID: 29222373].","DOI":"10.2337\/dc18-S002"},{"issue":"6","key":"1074_CR14","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/j.jacl.2016.08.013","volume":"10","author":"S Li","year":"2016","unstructured":"Li S, Zhang Y, Zhu CG, Guo YL, Wu NQ, Gao Y, Qing P, Li XL, Sun J, Liu G, Dong Q, Xu RX, Cui CJ, Li JJ. Identification of familial hypercholesterolemia in patients with myocardial infarction: a Chinese cohort study. J Clin Lipidol. 2016;10(6):1344\u201352. \n                    27919351\n                    \n                  .","journal-title":"J Clin Lipidol"},{"issue":"12","key":"1074_CR15","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1080\/17512433.2017.1378096","volume":"10","author":"G Polychronopoulos","year":"2017","unstructured":"Polychronopoulos G, Tziomalos K. Novel treatment options for the management of heterozygous familial hypercholesterolemia. Expert Rev Clin Pharmacol. 2017;10(12):1375\u201381. \n                    28884604\n                    \n                  .","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"18","key":"1074_CR16","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1001\/jama.2014.4030","volume":"311","author":"JG Robinson","year":"2014","unstructured":"Robinson JG, Nedergaard BS, Rogers WJ, Fialkow J, Neutel JM, Ramstad D, Somaratne R, Legg JC, Nelson P, Scott R, Wasserman SM, Weiss R, LAPLACE-2 Investigators. Effect of evolocumab or ezetimibe added to moderate- or high-intensity statin therapy on LDL-C lowering in patients with hypercholesterolemia: the LAPLACE-2 randomized clinical trial. JAMA. 2014;311(18):1870\u201382. \n                    24825642\n                    \n                  . \n                    https:\/\/doi.org\/10.1001\/jama.2014.4030\n                    \n                  .","journal-title":"JAMA."},{"key":"1074_CR17","doi-asserted-by":"publisher","unstructured":"Wilson PWF, Polonsky TS, Miedema MD, Khera A, Kosinski AS, Kuvin JT. Systematic Review for the 2018. AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018. Doi \n                    https:\/\/doi.org\/10.1016\/j.jacc.2018.11.004\n                    \n                  . [Epub ahead of print] [PMID: 30423394].","DOI":"10.1016\/j.jacc.2018.11.004"},{"issue":"1","key":"1074_CR18","doi-asserted-by":"publisher","first-page":"14","DOI":"10.15420\/ecr.2018:10:2","volume":"13","author":"Rodrigo Alonso","year":"2018","unstructured":"Alonso R, Perez de Isla L, Mu\u00f1iz-Grijalvo O, Diaz-Diaz JL, Mata P. Familial Hypercholesterolaemia diagnosis and management. Eur Cardiol 2018, 13(1):14\u201320. [PMID: 30310464].","journal-title":"European Cardiology Review"},{"key":"1074_CR19","doi-asserted-by":"publisher","first-page":"a2423","DOI":"10.1136\/bmj.a2423","volume":"337","author":"J Versmissen","year":"2008","unstructured":"Versmissen J, Oosterveer DM, Yazdanpanah M, Defesche JC, Basart DC, Liem AH, Heeringa J, Witteman JC, Lansberg PJ, Kastelein JJ, Sijbrands EJ. Efficacy of statins in familial hypercholesterolaemia: a long term cohort study. BMJ. 2008;337:a2423. \n                    19001495\n                    \n                  .","journal-title":"BMJ."},{"issue":"23","key":"1074_CR20","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1093\/eurheartj\/ehn422","volume":"29","author":"A Neil","year":"2008","unstructured":"Neil A, Cooper J, Betteridge J, Capps N, McDowell I, Durrington P, Seed M, Humphries SE. Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study. Eur Heart J. 2008;29(23):2625\u201333. \n                    18840879\n                    \n                  .","journal-title":"Eur Heart J"},{"key":"1074_CR21","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0140-6736(14)61702-5","volume":"385","author":"RD Santos","year":"2015","unstructured":"Santos RD, Watts GF. Familial hypercholesterolaemia: PCSK9 inhibitors are coming. Lancet. 2015;385:307\u201310. \n                    25282517\n                    \n                  . \n                    https:\/\/doi.org\/10.1016\/S0140-6736(14)61702-5\n                    \n                  .","journal-title":"Lancet."},{"key":"1074_CR22","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0140-6736(14)61399-4","volume":"385","author":"FJ Raal","year":"2015","unstructured":"Raal FJ, Stein EA, Dufour R, Turner T, Civeira F, Burgess L, Langslet G, Scott R, Olsson AG, Sullivan D, Hovingh GK, Cariou B, Gouni-Berthold I, Somaratne R, Bridges I, Scott R, Wasserman SM, Gaudet D, RUTHERFORD-2 Investigators. PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial. Lancet. 2015;385:331\u201340. \n                    25282519\n                    \n                  . \n                    https:\/\/doi.org\/10.1016\/S0140-6736(14)61399-4\n                    \n                  .","journal-title":"Lancet."}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-019-1074-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12944-019-1074-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-019-1074-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,30]],"date-time":"2020-05-30T23:08:47Z","timestamp":1590880127000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-019-1074-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1074"],"URL":"https:\/\/doi.org\/10.1186\/s12944-019-1074-8","relation":{},"ISSN":["1476-511X"],"issn-type":[{"type":"electronic","value":"1476-511X"}],"subject":[],"published":{"date-parts":[[2019,6,1]]},"assertion":[{"value":"6 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was complied with the Declaration of Helsinki and approved by the Institutional Ethics Committee of Beijing Anzhen Hospital. Written informed consent was not obtained from the participants, because of the data retrospectively obtained from electronic medical records.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"131"}}